Sofosbuvir and risk of estimated glomerular filtration rate decline or end‐stage renal disease in patients with renal impairment-Reference-Cited by-同舟云学术

Sofosbuvir and risk of estimated glomerular filtration rate decline or end‐stage renal disease in patients with renal impairment

Published:2022-03-02 Issue:9 Volume:55 Page:1169-1178
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Sulkowski Mark¹^ORCID,Telep Laura E.²,Colombo Massimo³,Durand Francois⁴,Reddy K. Rajender⁵,Lawitz Eric⁶,Bourlière Marc⁷⁸,Cheinquer Nelson²,Scherbakovsky Stacey²,Ni Liyun²,Force Lindsey²,Ramroth Heribert²,Gaggar Anuj²,Chokkalingam Anand P.²^ORCID,Sise Meghan E.⁹^ORCID

Affiliation:

1. Johns Hopkins University School of Medicine Baltimore Maryland USA

2. Gilead Sciences, Inc. Foster City California USA

3. M Colombo Liver Center San Raffaele Hospital Milan Italy

4. Hôpital Beaujon University Paris Diderot Clichy France

5. Department of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

6. Texas Liver Institute University of Texas Health Science Center San Antonio Texas USA

7. Hépato‐Gastro‐Entérologie Hôpital Saint Joseph Marseille France

8. INSERM 1252, IRD, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale Aix‐Marseille University Marseille France

9. Massachusetts General Hospital Boston Massachusetts USA

Funder

Gilead Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16830

Reference38 articles.

1. World Health Organization (WHO). Hepatitis C fact sheet. Available fromhttps://www.who.int/news‐room/fact‐sheets/detail/hepatitis‐c. Accessed 14 July 2020.

2. Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals

3. Natural history of hepatitis C

4. Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis

5. Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKD

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Fixed Dose Combination of Sofosbuvir and Velpatasvir is Safe and Effective in Patients of Chronic Hepatitis C With End-stage Renal Disease;Journal of Clinical and Experimental Hepatology;2024-07

2. Identifying Gaps in the Treatment Guidelines for Hepatitis C in Peru to Meet International Standards: A Narrative Review;Journal of Clinical Medicine;2024-06-30

3. Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease;Advances in Kidney Disease and Health;2023-07

4. Evaluation of Long-Term Outcomes of Direct Acting Antiviral Agents in Chronic Kidney Disease Subjects: A Single Center Cohort Study;Journal of Clinical Medicine;2023-05-17

5. How to use COVID-19 antiviral drugs in patients with chronic kidney disease;Frontiers in Pharmacology;2023-02-09